EVIDENCE VS HYPE · CREATINE & AGEING
The hype: Creatine is no longer just a gym supplement: it can stop age-related muscle loss and keep you strong and independent.
That is an appealing promise. Carrying shopping, getting out of a chair and remaining active matter more than a bodybuilding photograph. But an improvement in a laboratory strength test is not automatically proof that a supplement prevents frailty. We investigated whether creatine monohydrate adds worthwhile benefits to resistance training in older adults.
The short answer
Creatine can modestly improve strength gains alongside resistance training in generally healthy older adults. Evidence for additional muscle mass is less consistent, and prevention of falls, disability or loss of independence has not been established. It is an optional addition to training, not a substitute for movement, adequate nutrition or treatment for diagnosed sarcopenia.
Why people believe it
Muscle stores creatine and phosphocreatine, which help replenish energy during demanding contractions. If a supplement helps someone perform slightly more training, that could support adaptation over time. Older people can gain strength through appropriately progressed resistance exercise, so the mechanism is plausible. However, ageing also involves illness, activity, appetite and many other influences that a scoop of powder cannot resolve.
The precise claim here is extra benefit from creatine compared with the same resistance programme without it. Evidence that exercise itself works does not prove that creatine contributes an additional improvement.
What the evidence says
Strength: a modest additional benefit
A 2026 systematic review by Yao and colleagues pooled 11 randomised trials in adults aged 60 or older. Its analysis accounted for multiple outcomes from the same trial. Adding creatine to resistance training produced a small average strength advantage: standardised effect 0.31, with a 95% confidence interval of 0.18–0.45. The authors judged this evidence moderate certainty. A standardised effect combines different tests; it does not mean every person can lift 31% more.
Muscle mass and physical function were less clear. Their pooled estimates had confidence intervals crossing no difference, and certainty was low or very low. Most participants were relatively healthy and living in the community. The review reported no funding or commercial conflicts. Read Yao et al., 2026, Frontiers in Nutrition.
Other reviews support benefits, but not identical conclusions
Sharifian and colleagues' 2025 review included 20 studies and 1,093 adults aged at least 55. It also found favourable strength outcomes, while bone mineral density did not improve significantly. Different age thresholds, trials and methods can change pooled estimates. This review reported no funding and no competing interests. Its findings help establish that the strength result is not based on a single experiment, but overlapping reviews are not independent sets of participants. Read Sharifian et al., 2025, European Review of Aging and Physical Activity.
A separate 2026 review specifically examined postmenopausal women: seven trials randomised 608 participants over 12–104 weeks. The lean-mass analysis, based on five trials and 338 participants, favoured creatine by approximately 0.37 kg. Three smaller trials found an average leg-press advantage of 7.5 kg. Bone density did not improve. Benefits depended on the outcome and available studies; these figures are group averages, not a guaranteed personal result. Read the 2026 postmenopausal-women systematic review.
More lean mass does not always mean more useful muscle
Body-composition measurements include water as well as tissue. Creatine can increase muscle water, particularly early in supplementation. A larger lean-mass measurement therefore needs interpretation alongside strength, duration and functional tests. A few extra repetitions or a better leg-press result may be useful, but cannot establish that someone will avoid a fall or need less help at home.
The catch: what the research cannot establish
Many trials are small, use different training programmes and doses, and recruit people willing and able to exercise. Those participants may differ from someone with substantial frailty, multiple illnesses or severe mobility restrictions. The newest review explicitly warns against generalising its findings to frail or sarcopenic populations. There is no basis for turning a modest training benefit into an anti-ageing claim.
Nor does the evidence show that everyone over a particular birthday should supplement. Starting strength, dietary intake, adherence and training quality vary. The trials chiefly evaluate creatine with exercise; they do not establish comparable benefits from taking it while remaining inactive. Long-term outcomes such as fractures, care needs and disability require larger, targeted trials.
How strong is the evidence?
What this means for you
Prioritise a resistance programme you can sustain and progress safely. That might use machines, free weights, bands or appropriately challenging body-weight movements. If health conditions or mobility difficulties complicate training, tailored professional advice can make the programme more useful than choosing a supplement first.
Plain creatine monohydrate is the form to consider; expensive proprietary blends have not earned an advantage here. A daily 3–5 g approach is common in general use, although older-adult trials have used varied protocols and sometimes weight-based doses. This is not a personalised prescription. Read the label and discuss supplementation with a clinician if you have kidney disease, significant illness or take medicines that require kidney monitoring.
A 2025 narrative review describes reassuring safety findings in studied older adults, but also important gaps involving comorbidities and medication interactions. Creatine can influence creatinine blood measurements; tell the person interpreting your tests that you take it. Read the 2025 older-adult and clinical-population review.
Judge progress through useful measures—your training record and activities that matter to you—rather than expecting a dramatic transformation. Adequate food, protein and recovery still matter. Supplementation is optional, and choosing not to use it does not prevent successful strength training.
The Evidence vs Hype verdict
Creatine has a credible place as an adjunct to resistance exercise in older adults. The clearest finding is a modest strength benefit. Calling it a proven solution for frailty, osteoporosis or independence goes beyond the research.
Research & Sources
- Yao et al. (2026). Resistance training plus creatine in older adults. Systematic review and three-level meta-analysis.
- Sharifian et al. (2025). Systematic review and meta-analysis.
- Postmenopausal women (2026). Systematic review and meta-analysis.
- Older adults and clinical populations (2025). Narrative review.
Evidence reviewed: October 2026. This is an editorial evidence assessment, not independent clinical peer review or individual medical advice. No commercial product is endorsed in this investigation. Any optional recommendations are separate from the scientific verdict; see our affiliate disclosure.